T/CMEAS 012-2023 Active Group standards

T/CMEAS 012-2023 Risk Management Standards for High-Alert Medication in Healthcare Institutions

T/CMEAS 012-2023 Risk Management Standards for High-Alert Medication in Healthcare Institutions

Publish Date: 2023-09-28 Implement Date: 2023-09-28 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CMEAS 012-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine
ICS Name: Comprehensive Pharmaceutical Science
Publish Date: 2023-09-28
Implement Date: 2023-09-28

Scope

Main technical content: This document specifies the risk management elements of high-alert drugs in medical institutions, the formulation and graded management of the high-alert drug catalog, as well as the risk management of high-alert drugs in storage, prescription, dispensation, use, and adverse drug reaction/event monitoring, and the management of high-alert drug training. This document is applicable to the risk management of high-alert drugs in all medical institutions.

Development Information

Related Standards

Contact Us